119th Congress · HOUSE BILLBILL

H.R. 5160Stem Cell Therapeutic and Research Reauthorization Act of 2025

To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.

Health
Introduced Sep 4, 2025
Last action Jul 21, 2026
Pipeline · Bill → Law
Step 1
Introduced
Sep 4, 2025
Step 2
Referred
Sep 4, 2025
E&C
Step 3
Committee
May 21, 2026
Reported out
Step 4
House floor
Jul 20, 2026
Passed House
Step 5
Senate
Jul 21, 2026
Step 6
Resolve Changes
Step 7
Signed
SummaryNo summary available

No CRS summary available for this bill.

Provisions · 3 sectionsEngrossed in House
3 versions
Engrossed in House · 3 provisions
Timeline · 17 actions
Jul 21, 2026
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.
Jul 20, 2026
Motion to reconsider laid on the table Agreed to without objection.
Jul 20, 2026
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)
Jul 20, 2026
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
Jul 20, 2026
DEBATE - The House proceeded with forty minutes of debate on H.R. 5160.
Jul 20, 2026
Considered under suspension of the rules. (consideration: CR H4642-4643)
Jul 20, 2026
Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
Jul 20, 2026
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)
Jul 2, 2026
Placed on the Union Calendar, Calendar No. 629.
Jul 2, 2026
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.
May 21, 2026
Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
May 21, 2026
Committee Consideration and Mark-up Session Held
May 13, 2026
Forwarded by Subcommittee to Full Committee by Voice Vote.
May 13, 2026
Subcommittee Consideration and Mark-up Session Held
Sep 4, 2025
Introduced in House
Sep 4, 2025
Referred to the House Committee on Energy and Commerce.
Sep 4, 2025
Referred to the Subcommittee on Health.